GIST Cancer Research Fund
GCRF would like to thank JULIE CRAMER for spearheading another wonderful event. Held on Feb 23rd at the Merion, in Cinnaminson, NJ. This annual event raises money to help eradicate GIST. Julie began the event to honor the memory of her dad, Mark Becker.
2012 Peter Thomas
The GIST Cancer Research Fund’s Cycling Warriors took to the road on October 23, 2012 for their 1,000-mile, 10-day crusade in the fight against GIST Cancer.
The spirit of Peter Thomas led the way and along with Riette and Dylan Thomas (and Wayne Thomas in tow), the riders began and ended a triumphant journey along the rugged South Africa coast.
It all started in Gordon’s Bay and concluded in Cape Town. It was the toughest and most challenging of the three Peter Thomas Memorial Rides For A Cure. It stretched the riders physically, mentally and emotionally. They crossed fourteen mountain passes and endured gale force headwinds that were so strong that it almost blew the riders off their bikes.
While each cyclist came for a different reason on this trip, the camaraderie and banter amongst the group was certainly a unique experience for many. You do have to ask yourself the question, why some come back to do this grueling ride every three years? Through all the adversity, this fantastic group of GIST Cyclists left their jobs, families and comforts of home to cycle 1,000 miles in 10 days to raise money for the GIST More »
PITTSBURGH, Aug. 23, 2012 – For the seventh year in a row, researchers from the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, have received funding from the GIST Cancer Research Fund – a patient-driven organization that funds research on gastrointestinal stromal tumors (GISTs). These tumors occur in the gastrointestinal tract and initially can be successfully treated with the targeted therapy drug Gleevec, but rapidly develop resistance to the treatment.
The GCRF has made available the various updates and technical presentations from recently held sponsored events. These include:
Advances in GIST Surgery - Chandrajit P. Raut, MD (video)
Clinical Aspects of GIST – Dr. David DeAdamo (video)
Advances in GIST Therapy #2 (KIT/PDGFRA Downstream Targets) - James E. Butrynski, MD (video)
Advances in “Wildtype” and Pediatric GIST - Katherine A. Janeway, MD (video)
GIST Myth Busters - Amy Pilotte, NP and Kathleen Polson, NP (video)
Identifying Vulnerabilities in Drug Resistant GIST - Jonathan A. Fletcher, MD (video)
High-throughput Methods to Identify Drug Targets - Cesar Serrano Garcia, MD (video)
Murine models of imatinib-resistant GIST – Dr. Benedikt Bosbach (video)
Update in Pediatric and Wild-type GIST – Dr. Cristina Antonescu (video)
Phase II study of the Hsp90 Inhibitor BIIB021 in GIST – Dr. Mark Dickson (video)
Update in targeting the immune response in GIST – Dr. Ron DeMatteo (video)
Update on CTLA4 clinical trial – Dr. Richard Carvajal (video)
Advanced interventional radiologic techniques for GIST liver metastases - Dr. Karen Brown (video)